Comerica Securities’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | $9.08M | Sell |
60,901
-4,107
| -6% | -$603K | 0.75% | 34 |
|
|
2023
Q2 | $8.76M | Sell |
65,008
-15,415
| -19% | -$2.26M | 0.61% | 41 |
|
|
2023
Q1 | $12.8M | Sell |
80,423
-3,885
| -5% | -$594K | 0.93% | 21 |
|
|
2022
Q4 | $13.6M | Sell |
84,308
-1,099
| -1% | -$169K | 0.97% | 18 |
|
|
2022
Q3 | $11.5M | Sell |
85,407
-1,578
| -2% | -$226K | 0.94% | 24 |
|
|
2022
Q2 | $13.3M | Sell |
86,985
-11,529
| -12% | -$1.76M | 1.01% | 21 |
|
|
2022
Q1 | $16M | Sell |
98,514
-4,463
| -4% | -$648K | 1.07% | 19 |
|
|
2021
Q4 | $13.9M | Buy |
102,977
+2,283
| +2% | +$270K | 0.89% | 26 |
|
|
2021
Q3 | $10.9M | Buy |
100,694
+3,017
| +3% | +$345K | 0.77% | 32 |
|
|
2021
Q2 | $11M | Sell |
97,677
-1,909
| -2% | -$215K | 0.83% | 31 |
|
|
2021
Q1 | $10.8M | Sell |
99,586
-5,663
| -5% | -$606K | 0.82% | 27 |
|
|
2020
Q4 | $11.3M | Sell |
105,249
-1,732
| -2% | -$166K | 0.9% | 25 |
|
|
2020
Q3 | $9.37M | Buy |
106,981
+1,962
| +2% | +$185K | 0.84% | 35 |
|
|
2020
Q2 | $10.3M | Buy |
105,019
+1,554
| +2% | +$137K | 0.98% | 22 |
|
|
2020
Q1 | $7.88M | Buy |
103,465
+1,441
| +1% | +$123K | 0.89% | 26 |
|
|
2019
Q4 | $9.03M | Buy |
102,024
+72,699
| +248% | +$6.04M | 0.86% | 20 |
|
|
2019
Q3 | $2.22M | Buy |
29,325
+2,656
| +10% | +$182K | 0.23% | 107 |
|
|
2019
Q2 | $1.94M | Sell |
26,669
-20,215
| -43% | -$1.59M | 0.21% | 117 |
|
|
2019
Q1 | $3.78M | Sell |
46,884
-2,287
| -5% | -$187K | 0.42% | 65 |
|
|
2018
Q4 | $4.53M | Sell |
49,171
-316
| -0.6% | -$27.8K | 0.6% | 43 |
|
|
2018
Q3 | $4.68M | Sell |
49,487
-1,986
| -4% | -$188K | 0.55% | 44 |
|
|
2018
Q2 | $4.77M | Buy |
51,473
+490
| +1% | +$47.9K | 0.58% | 42 |
|
|
2018
Q1 | $4.83M | Sell |
50,983
-9,679
| -16% | -$1.06M | 0.61% | 36 |
|
|
2017
Q4 | $5.87M | Sell |
60,662
-3,822
| -6% | -$360K | 0.74% | 25 |
|
|
2017
Q3 | $5.73M | Sell |
64,484
-3,447
| -5% | -$262K | 0.79% | 23 |
|
|
2017
Q2 | $4.93M | Buy |
67,931
+1,488
| +2% | +$100K | 0.73% | 23 |
|
|
2017
Q1 | $4.33M | Buy |
+66,443
| New | +$4.18M | 0.68% | 27 |
|
|
2015
Q4 | – | Sell |
-56,390
| Closed | -$3.07M | – | 179 |
|
|
2015
Q3 | $3.07M | Buy |
56,390
+48,573
| +621% | +$3.16M | 1.81% | 4 |
|
|
2015
Q2 | $525K | Sell |
7,817
-488
| -6% | -$31.9K | 0.13% | 180 |
|
|
2015
Q1 | $486K | Buy |
+8,305
| New | +$502K | 0.13% | 181 |
|
|
2014
Q3 | – | Sell |
-4,064
| Closed | -$229K | – | 150 |
|
|
2014
Q2 | $229K | Buy |
4,064
+44
| +1% | +$2.31K | 0.21% | 106 |
|
|
2014
Q1 | $207K | Buy |
+4,020
| New | +$203K | 0.2% | 111 |
|
Other funds holding ABBV
Comerica Securities's ABBV Position: Q3 2023 in Review
Comerica Securities reduced its AbbVie (ABBV) stake by 6.3% in Q3 2023, selling an estimated $603K and leaving 60,901 shares worth $9.08M. The position accounts for 0.75% of the portfolio, ranked #34.
Comerica Securities first reported a position in ABBV in Q1 2014 and has held it in 32 quarters since. The position peaked at $16M in Q1 2022. 3,108 funds tracked by Wall St. Rank hold ABBV as of Q3 2023.
- Comerica Securities held 60,901 shares of AbbVie worth $9.08M as of Q3 2023.
- Comerica Securities sold 4,107 AbbVie shares in Q3 2023, an estimated $603K.
- AbbVie made up 0.75% of Comerica Securities's portfolio in Q3 2023, its #34 holding.
- Comerica Securities first reported a position in AbbVie in Q1 2014 and has held it in 32 quarters since.
- Comerica Securities's AbbVie position peaked at $16M in Q1 2022.
- 3,108 funds tracked by Wall St. Rank held AbbVie as of Q3 2023.
Based on Comerica Securities's 13F filing for Q3 2023, filed 26 Oct 2023.